{
    "links": "https://www.ycombinator.com/companies/invision-medical-technology",
    "name": "InVision Medical Technology",
    "headline": "AI Diagnosis of  Heart Disease",
    "batch": "S22",
    "description": "At InVision, we use AI to help streamline the interpretation of ultrasounds and identify diseases that may have been missed by human readers. Our models have been tightly integrated into the clinical workflow to allow easy usage by clinicians. Our work has previously been peer-reviewed and published in several top medical venues, including Nature (2020), Nature Medicine (2021), Lancet Digital Health (2021), JAMA Cardiology (2022). Results from our blinded and randomized clinical trial on evaluating cardiac function have also been recently presented as a Late Breaking Clinical Trial at the European Society of Cardiology.",
    "activity_status": "Active",
    "website": "http://invisionmedtech.com/",
    "founded_date": 2022.0,
    "team_size": 2.0,
    "location": null,
    "group_partner": null,
    "group_partner_yc": null,
    "company_linkedin": null,
    "company_twitter": null,
    "tags": "industry:artificial-intelligence; industry:health-tech; industry:diagnostics",
    "founders": [
        {
            "name": "David Ouyang, Founder",
            "description": "MD 2014, UCSF\nInternal Medicine Residency 2017, Stanford\nCardiology Fellowship 2020, Stanford\nCardiologist, Cedars Sinai Medical Center",
            "linkedin": "https://www.linkedin.com/in/davidouyang/"
        },
        {
            "name": "Bryan He, Founder",
            "description": "PhD Computer Science 2022, Stanford University\nBS Computer Science 2015, California Institute of Technology",
            "linkedin": null
        }
    ],
    "status": true,
    "generated_description": "**InVision Medical Technology: Innovating Heart Disease Diagnosis with AI**\n\nFounded in 2022 and part of Y Combinator's Batch S22, InVision Medical Technology is carving its niche in the healthcare landscape with cutting-edge AI technology aimed at diagnosing heart disease. The company utilizes artificial intelligence to enhance the interpretation of heart ultrasounds\u2014a critical diagnostic tool that can sometimes be misread by human clinicians. \n\n### Mission and Impact\n\nInVision\u2019s mission focuses on improving the detection of heart disease, leveraging AI to identify conditions that might have been overlooked. Their models are seamlessly integrated into clinical workflows, allowing practitioners to utilize them easily and effectively. Notably, their work has gained recognition, with peer-reviewed publications in esteemed journals like *Nature* and *JAMA Cardiology* and their recent clinical trial findings presented at a major European cardiology conference.\n\n### Team and Location\n\nLocated in an undisclosed area and operated by a lean team of two, InVision is positioned to make a substantial impact in the health-tech field. Despite its size, the company is ambitious, targeting the staggering 32 million ultrasound exams performed annually in the U.S., each requiring over an hour of physician and technician time.\n\n### Product and Future Plans\n\nInVision Medical Technology is busy developing and refining AI tools for interpretation of cardiac ultrasounds. Their website offers additional resources, including product tours, features, and customer insights. They're keen on collaboration and encourage anyone interested in their innovations to get in touch through their contact details.\n\n### Concluding Thoughts\n\nInVision Medical Technology is a promising startup at the intersection of artificial intelligence and health diagnostics. With a strong foundation and a clear mission, they stand to benefit not only practitioners but, more importantly, patients who may receive faster and more accurate diagnoses of heart conditions. For more information, you can visit their website at [InVision Medical Technology](http://invisionmedtech.com/). \n\nIf you\u2019re looking to elevate your practice or learn more about their innovations in cardiac diagnostics, don\u2019t hesitate to reach out to their founders at founders@invisionmedtech.com.",
    "logo": "https://bookface-images.s3.us-west-2.amazonaws.com/logos/7ae8739282c9415492ed763300a32725b5dc080b.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=ASIAQC4NIECAEHIR6H6F%2F20250221%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20250221T191437Z&X-Amz-Expires=3600&X-Amz-Security-Token=IQoJb3JpZ2luX2VjELP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDt736ZW5EfzagAz1eKRSs%2FW4TfHu28RBSFaRNkZ9h47gIhANt6WXtwkgL07bQKDKYDGFxYKx7WOO9JX0BqaYrXnKNbKu4DCNz%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMMDA2MjAxODExMDcyIgx8TqkMwTM2PLcRmr4qwgPGGtQBXv7gs7%2BXGteI1gQk%2FjkbIHwQ5hCKXJKVmVAPw3MeVLhZyp8Nf5%2FYigbwE%2BrFR7aZWKjrs7HxAE0JWit5dlINZLjZK%2BS%2FwMaCqoj%2BFDN0gw9iiAPu4Xn5c3b%2BuZe%2F5%2Flfk0EuxZAXVsZtShxXZy%2FERPQ0v%2FRZxSz5qUoaXpL1zj6VWdWVzoI7%2FPlB3bgJ2PpiF7DN%2BJeDsJPx%2FoKTo5ehP9pOeGbMNxoeegVJsCJ3zvzO3o4fcZYIf6c5iIJwM1Ot3Gg7Z3v9oLZjSRU%2FaRLL5j4n3II7DaroOCEVfPlWzTyZM7SNFZZAFSKM8vLKj1VdTr9s3How41zluf%2FOIp7sGNhG%2FjuYJoG%2FmkLFIlYP4wbGrLO69AWnenZyfi1UhAiV6N%2BlAqGnqvpOJh4vq8uNh2eRnXR%2BMVXdq9oVYkm7XFgprL5PDC4ULLyBWqA6kca4z7F4H56nkT%2FsDtT8ek2VOIRIv1Zgcz%2BeeVG7F7AHS4bdbR6eZ3ChY1iQhfPBErh4OiFQM7IqiUKw%2B1CTpvL68xcVN5gjiaDH0Jotw%2BUcW9dMSg9py8xH8qgyiWG5w3dDj9xaoA2G3NMYq6JOGKMwwIrjvQY6pAHDH54nhADhmb7YSEGxHkL3pqs%2B6aYOExStWbzLKzRb3lb2DAgGG8uU9COt8%2FqUEOtOcszTKp7yuCJwMVkfI7PDZ74h9uiRkRxjtH7%2BLlE1xrfd%2FrIq%2B%2BZr9hSFqZ9MUQ4yNHesyx2FYDbsIfCW9ntlrpmZUHCcrzpQDfufsAFcpe%2FudVT3tUqiF8WCN1Vd%2Bx%2FQ9d3i1HvBcJWV9AYAwM0W22VM%2BA%3D%3D&X-Amz-SignedHeaders=host&X-Amz-Signature=2df6eef8fbadd3ffbf854b590079079c85d7e843dd9f795805c5dce7bde84cb2",
    "social_links": [],
    "logo_path": "data/logos\\InVision_Medical_Technology_logo.png"
}